![]() ![]() listing by a Chinese firm on record, after Alibaba Group Holding Ltd.’s $25 billion blockbuster debut in 2014. this year, according to data compiled by Bloomberg. Backed by Alibaba Health Information Technology Ltd (0241.HK), LinkDoc filed for its IPO last month and was due to price its shares after the U.S. Date of experience: OctoBE Ben 3 reviews GB Two Years Of Great Service I have worked with LinkDoctor for two years now. Its investors include Alibaba Health Information Technology Ltd., MBK Partners, New Enterprise Associates and Temasek Holdings Pte according to a preliminary filing.Ĭhinese companies have raised about $13 billion through first-time share sales in the U.S. They produce high-quality, high-value content and pitch it to real publications, landing organic placements that readers love. Its service offerings comprise of clinical recruitment, real-world research services, data insight and other services based on precise life science solutions. ![]() LinkDoc, founded in 2014, provides cancer focused health-care services built on big data and artificial intelligence, its website shows. Latest LinkDoc Technology Share Price - Live LDOC share price quotes, charts, profile, RNS & company financials for NAQ:LDOC > Login Get Started. LinkDoc Technology Beijing Co Ltd (LinkDoc) is a medical big data company offering clinically structured solutions. A representative for LinkDoc declined to comment. Reuters reported LinkDoc’s IPO halt earlier Thursday. Valuation is a core or optional technical competency for a wide variety of APC pathways, including Commercial Real Estate, Corporate Real Estate, Planning and Development, Property Finance and Investment, Residential, Rural and Valuation. LinkDoc’s IPO delay also comes as regulators in Beijing are planning rule changes that would allow them to block a Chinese company from listing overseas even if the unit selling shares is incorporated outside China, closing a loophole long-used by the country’s technology giants, Bloomberg News reported this week. In the first three months of the year, the firm reported a 41 increase in revenue year-on-year, while net losses widened to 20.7 million yuan (21.17 million) from 61.6 million yuan (9.62 million) a year earlier. plunged after the government ordered the removal of the ride-hailing giant’s app from local app stores within days of its $4.4 billion U.S. According to its prospectus, LinkDoc Technology’s revenue for 2020 reached 1.07 billion. were arranging the deal.Ĭhinese technology stocks suffered a rout after China signaled a new era of tighter oversight over cybersecurity. LinkDoc was slated to price the offering on Thursday, which could have raised as much as $211 million. The Beijing, China-based company plans to raise 200 million by offering 10. continuing a trend that has seen some 823 billion wiped from their market value since a February peak, amid a raft of regulatory hits spanning financial risk. IPO as the fallout from China’s crackdown on data-rich companies listing overseas continues. Market volatility has played a part in the postponement and the Beijing-based medical data company could revisit its listing plans when conditions improve, said one of the people, who asked not to be identified as the information is private. LinkDoc Technology, a Chinese healthcare data company specializing in oncology patients, announced terms for its IPO on Thursday. Alibaba-backed medical data firm LinkDoc Technology Ltd. initial public offering, people familiar with the matter said, the first known company to pull out of a debut after China’s government cracked down on overseas listings. ![]() The case examines how LinkDoc, specializing in big data and serving the vertical healthcare industry, found its own answers to these issues and, more specifically, how it identified and entered its target market segment, and subsequently found a way to commercialize its technology and create a viable business.(Bloomberg) - LinkDoc Technology Ltd. The issue, then, is how tech start-ups should strike a balance between 'aiming too high' and 'taking a faster route.' The LinkDoc Technology (hereinafter 'LinkDoc") case was compiled as one way to find answers to these questions. Others aim for low-hanging fruit in more easily accessible markets, at the expense of pursuing their original goal once engaged on this path, it is extremely difficult to change course and build an iconic name. This case examines a universal question: How can a tech start-up (such as an AI or big data start-up) address the pain points of traditional vertical industries through technological innovation and create value? Some tech start-ups set ambitious goals, which demand significant and sustained investments in R&D, but fail to plan for commercial development in order to remain viable: when funding runs out, they go bust. ![]()
0 Comments
Leave a Reply. |